CDC recommends a second safe, effective COVID-19 vaccine for children 6 through 17 years of age

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation that Moderna's COVID-19 vaccine be used as an option for children ages 6 through 17 years, in addition to its already recommended use in children 6 months through 5 years and adults 18 years and older. This recommendation reinforces the use of […]

Continue reading »

Health system must collaborate to fix systemic causes of ambulance ramping

A study published in the Medical Journal of Australia, which assessed whether ambulance offload time influences the outcomes for patients experiencing cardiac issues, provides further evidence that access block is causing significant harm to patients. While there is currently no cardiac-specific data available in the emergency medicine literature, there is a substantive history of data that indicates, without doubt, that […]

Continue reading »

Virtual reality technology could strengthen effects of traditional rehabilitation for multiple sclerosis

In a recent article, Kessler Foundation scientists advocated for the incorporation of virtual reality (VR) technology in cognitive rehabilitation research in multiple sclerosis (MS). They presented a conceptual framework supporting VR as an adjuvant to traditional cognitive rehabilitation and exercise training for MS, theorizing that VR could strengthen the effects of traditional rehabilitative therapies by increasing sensory input and promoting […]

Continue reading »

RNA modifications in mitochondria promote invasive spread of cancer

Mitochondria are the power plants of cells, and they contain their own genetic material and RNA molecules. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered that certain modifications in mitochondrial RNA boost the invasive spread of cancer cells by supporting protein synthesis in mitochondria. They have established that a specific gene expression signature correlating with […]

Continue reading »

Protein discovered in Parkinson’s disease could lead to new treatments

Currently, there are no disease modifying therapies for Parkinson’s disease that can change the progression of the disease. An international team of scientists led by faculty at the University of Colorado Anschutz Medical Campus is hoping to change that. Today, they published new research in the journal Brain that takes scientists one step closer to understanding a key protein α-synuclein […]

Continue reading »

Mapping the ‘energy fingerprints’ of lung cancer leads to fundamental treatment rethink

Melbourne researchers have discovered that cancer and immune cells rely on the same energy sources from our body to thrive, which could trigger a fundamental rethink of treatment options for some lung cancer patients. The WEHI-led study found a method currently used to treat an aggressive form of lung cancer in clinical trials inadvertently prevents immune cells from protecting the […]

Continue reading »

Key protein α-synuclein linked to inflammation and Parkinson's disease

Currently, there are no disease modifying therapies for Parkinson's disease that can change the progression of the disease. An international team of scientists led by faculty at the University of Colorado Anschutz Medical Campus is hoping to change that. Today, they published new research in the journal Brain that takes scientists one step closer to understanding a key protein α-synuclein […]

Continue reading »
1 402 403 404 405 406 1,322